SOSV IndieBio Genesis Consortium III, L.P.

Fund· Delaware
Vintage
2025
Form D sold
$7.0M
Reported gross assets
$4.0M
Form ADV, Mar 23, 2026
FundraisingEvergreen or indefinite offeringADV: Venture Capital Fundmanager not yet resolved
More
As of · the latest observation of this vehicle; each figure below carries its own filing date

What matters now

  1. $7M
    sold at the filing

    Latest Form D filed on 26 Jun 2026: $7M sold, 5 investors. A Form D amount is what was sold at the filing, never a final close.

    A new or amended Form D means the vehicle is taking money now.

    FactSEC Form DFor LPs, placement agentsFundraising evidence →
Drawing the relationship network…
Amounts, each with its basis
Vintage
2025basis: form d first sale
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
indefinitewhat may be sold, not what was raised; file 021-549883, sworn by the adviser or filed under this vehicle
Form D sold
$7.0Mas of the filing of Jun 26, 2026, 5 investors
First sale
Jun 26, 2025
Reported GAV
$4.0Mon the Form ADV filed Mar 23, 2026; the fund's assets, never its size or dry powder
Owners (ADV)
34
Reported on ADV
unknown
Fundraising evidence
Evergreen or indefinite offering
Form D filed or amended 2026-06-26: offering indefinite, sold $7.0M (fr-1)
evidence dated Jun 26, 2026.
Lifecycle
Fundraising
Form D within 18 months and the offering is not sold out
first sale: Jun 26, 2025vintage year: 2025adv gav as of: Mar 23, 2026vintage basis: Form d first saleform d sold: $7.0Mform d offering: n/aform d latest filed at: Jun 26, 2026
The fund's own reporting through time
1 Form ADV filings
FiledTypeGross asset value OwnersMin. investmentAdviser-ownedAudit
Mar 23, 2026Venture Capital Fund$4.0M
34$500,0005%
Principals and agents
2 principals on Form D, 0 placement agents
Service providers
none named
No auditor, administrator, custodian or placement agent is named for this vehicle on a filing DFX holds.
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Known LPs and allocators
0 relationships, public pensions and the allocator graph, each counted once
No allocator names this vehicle in a public disclosure DFX holds: pension reports, foundation 990-PF returns or endowment disclosures.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
3 events
  1. Jun 26, 2026
    SOSV IndieBio Genesis Consortium III, L.P. filed Form D/A: $7,000,000 sold (indefinite offering), Venture Capital Fund
    Form D filed Fact Form D
  2. Mar 23, 2026
    Sosv Indiebio Genesis Consortium III LP first reported on Form ADV by Sosv Investments LLC (f/k/a Sosventures LLC) (Venture Capital Fund), GAV $4,000,000
    Fund first reported on Form ADV Inference Form ADV
  3. Jun 25, 2025
    SOSV IndieBio Genesis Consortium III, L.P. filed Form D: no sales yet (indefinite offering), Venture Capital Fund
    Form D filed Fact Form D
Evidence
31 observations
Every observation on this vehicle
  • Entity type: Limited Partnership Jun 26, 2026 Fact Form D
  • Entity type: Limited Partnership Jun 25, 2025 Fact Form D
  • Form D fund type: Venture Capital Fund Jun 26, 2026 Fact Form D
  • Form D fund type: Venture Capital Fund Jun 25, 2025 Fact Form D
  • Form D industry group: Pooled Investment Fund Jun 26, 2026 Fact Form D
  • Form D industry group: Pooled Investment Fund Jun 25, 2025 Fact Form D
  • Amendment: true Jun 26, 2026 Fact Form D
  • Amendment: false Jun 25, 2025 Fact Form D
  • Revenue range (Form D): Decline to Disclose Jun 26, 2026 Fact Form D
  • Revenue range (Form D): Decline to Disclose Jun 25, 2025 Fact Form D
  • Incorporated: withinFiveYears Jun 26, 2026 Fact Form D
  • Incorporated: withinFiveYears Jun 25, 2025 Fact Form D
  • Jurisdiction: Delaware Jun 26, 2026 Fact Form D
  • Jurisdiction: Delaware Jun 25, 2025 Fact Form D
  • Amount sold (Form D): $7.0M Jun 26, 2026 Fact Form D
  • Amount sold (Form D): $0 Jun 25, 2025 Fact Form D
  • Exemptions: 06b, 3C, 3C.1, 3C.7 Jun 26, 2026 Fact Form D
  • Exemptions: 06b, 3C, 3C.1, 3C.7 Jun 25, 2025 Fact Form D
  • First sale: 2025-06-26 Jun 26, 2026 Fact Form D
  • Indefinite offering: true Jun 26, 2026 Fact Form D
  • Indefinite offering: true Jun 25, 2025 Fact Form D
  • Investors (Form D): 5 Jun 26, 2026 Fact Form D
  • Investors (Form D): 0 Jun 25, 2025 Fact Form D
  • Minimum investment (Form D): 0 Jun 26, 2026 Fact Form D
  • Minimum investment (Form D): 0 Jun 25, 2025 Fact Form D
  • Securities offered: pooled Jun 26, 2026 Fact Form D
  • Securities offered: pooled Jun 25, 2025 Fact Form D
  • Office address: Jun 26, 2026 Fact Form D
  • Office address: Jun 25, 2025 Fact Form D
  • Year of incorporation: 2024 Jun 26, 2026 Fact Form D
  • Year of incorporation: 2024 Jun 25, 2025 Fact Form D

Relationships across DFX

on 1 other DFX graph
Across the graphs

SOSV IndieBio Genesis Consortium III, L.P. is the same institution as 1 record in RIA and Wealth.

RIA and Wealth1

The joined record opens with the product, beside every other relationship on this page.

Checking your plan…

Record history

3 dated events on the change ledger, latest event first
  • Form D filed
    2026-06-26source on record
  • Fund first reported on ADV
    2026-03-23source on record
  • Form D filed
    2025-06-25source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.